Alzheon, a privately-held clinical-stage biopharma company, presented promising Phase III APOLLOE4 trial results for ALZ-801 ...

Italy-based Angelini Ventures, the corporate venture arm of Angelini Industries, has named Regina Hodits as managing director ...

Belgium’s influential biopharma industry is showing signs of strain for the first time in years, with both employment and ...

French pharma major Sanofi and investment firm Cathay Capital have launched a $275 million fund that will invest in ...

German biotech Ethris, a company developing RNA therapeutics and vaccines, and Swiss contract development and manufacturing ...

South Korean clinical-stage biotech ABL Bio (Kosdaq: 298380) on Sunday announced a worldwide licensing agreement enabling GSK ...

UK-based developer of novel immunoglobulin E (IgE) antibodies to treat cancer, Epsilogen, says it has completed the ...

Thousands of workers dismissed from the US Department of Health and Human Services this week may soon be reinstated, after ...

China-based biotech DualityBio has named Hua Mu as its global chief medical officer, as the company prepares to ramp up its ...

Israel-based Teva Pharmaceuticals industries (NYSE: TEVA) today revealed two important updates reflecting its commitment to ...

The European Commission (EC) has approved an indication extension of Darzalex (daratumumab) subcutaneous (SC) formulation in ...

USA-listed biotech CASI Pharmaceuticals (Nasdaq: CASI) has received a revised proposal from its chairman and chief executive ...